GenScript’s 2026 Life Science Research Grant Program provides funding and scientific support for researchers working in areas including AI-driven drug discovery, antibody development, cell and gene therapy, vaccines, diagnostics, and biologics. The program offers four grant opportunities with awards ranging from up to $10,000 to $500,000, provided as credits for GenScript products and services rather than cash. The program is open to eligible researchers and organizations worldwide, with applications for the 2026 cycle accepted from July 8 through October 5, 2026.
